Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

AREV Life Sciences Global Corp C.AREV

Alternate Symbol(s):  AREVF

AREV Life Sciences Global Corp. is a Canada-based biotechnology company engaged in the discovery and commercialization of solutions for health and wellness. It produces ingredients and formulates therapeutic interventions in clinical nutrition, supplements, topicals and rational drug design, based on science. Its nutraceutical product formulations are sold under its BARE and Wright and Well brands. Its BARE and Wright and Well Brands of finished products include natural health products, including cannabidiol (CBD)-infused products such as Canna-Mulsion and NaturVax, an anti-viral supplement; NaturRelax, a natural Sleep Aid; Natur Relief, an anti-inflator and pain relief product, and a line of CBD skincare products and medicinal oils and edibles. Its Ready-to-Use Therapeutic Food (RUTF) for Severe Acute Malnutrition (SAM), with its branded RUTF known as SUS-TAINN (Superior Utility Supplementation Therapeutic Agent for Indicated Nutritional Needs), and RESTORE is under development.


CSE:AREV - Post by User

Comment by kash74on Apr 21, 2003 10:22am
150 Views
Post# 6034016

RE: AMAZING NEWS TODAY...

RE: AMAZING NEWS TODAY...I still have a lot of eggs in this basket, and I’m sure we will all be rewarded for the long haul. However I think it’s going to be at least 3 or 4 quarters of solid earnings before we see any significant increases in share price, ($1 to $2). If you do the math, GNS will be paying off OSTE for the next 5 years. And 1.3 million of your bottom line every year doesn’t help the share price. Nevertheless, with a few consecutive quarters of good earnings under their belts should be enough to convince investors of solid and accountable future earnings, obviously boosting a higher share price. I’m not ready “for” rumble just yet RED. But the recent climb definitely helps my attitude.
Bullboard Posts
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse